Publications

Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties.

The full article can be read and downloaded here

Please contact us via info@rheavita.com if you wish to learn more about how continuous freeze-drying enables the stabilization of your mRNA therapy for distribution and storage.

For formulation development, the freeze-drying process development, and production, we can be your partner in getting your therapy fast to the market with the highest quality while avoiding cold chain logistics.

Implementing PAT for real-time product monitoring and control during continuous freeze-drying can be read and downloaded here

Avoiding cold chain logistics can be read and downloaded here